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Abstract
Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) generates inorganic pyrophosphate (PPi), a physiologic inhibitor of
hydroxyapatite deposition. In a previous study, we found NPP1 expression to be inversely correlated with the degree of atherosclerotic
plaque calcification. Moreover, function-impairing mutations of ENPP1, the gene encoding for NPP1, are associated with severe, artery
tunica media calcification and myointimal hyperplasia with infantile onset in human beings. NPP1 and PPi have the potential to modu-
late atherogenesis by regulating arterial smooth muscle cell (SMC) differentiation and function, including increase of pro-atherogenic
osteopontin (OPN) expression. Hence, this study tested the hypothesis that NPP1 deficiency modulates both atherogenesis and ather-
osclerotic intimal plaque calcification. Npp1/ApoE double deficient mice were generated by crossing mice bearing the ttw allele of Enpp1
(that encodes a truncation mutation) with ApoE null mice and fed with high-fat/high-cholesterol atherogenic diet. Atherosclerotic lesion
area and calcification were examined at 13, 18, 23 and 28 weeks of age. The aortic SMCs isolated from both ttw/ttw ApoE/ and ttw/
ApoE/ mice demonstrated decreased Opn expression. The 28-week-old ttw/ttw ApoE/ and ttw/ ApoE/ had significantly smaller
atherosclerotic lesions compared with wild-type congenic ApoE/ mice. Only ttw/ttw but not ttw/ mice developed artery media cal-
cification. Furthermore in ttw/ mice, there was a tendency towards increased plaque calcification compared to ApoE/ mice without
Npp1 deficiency. We conclude that Npp1 promotes atherosclerosis, potentially mediated by Opn expression in ApoE knockout mice.
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Introduction
Plaque calcification is a biomarker of early atherosclerosis [1] and
correlates with complication, severity and plaque stability [2, 3].
Whereas arterial calcification in aging, diabetes mellitus and 
end-stage renal disease is primarily confined to the medial layer,
calcification in atherosclerosis occurs in the intimal plaque. Both
intima and media calcification appear to be mediated by ectopic
cartilage and bone formation, a consequence of the now well-
documented transdifferentiation potential of vascular smooth muscle
cells (SMCs) [4, 5] and also of osteochondral differentiation by
other cells in the artery, including adventitial myofibroblasts [6],
stem cells and pericytes [7–9] . The differentiation to ‘bone-forming’
chondrocyte- or osteoblast-like cells is accompanied by the expression
of tissue-nonspecific alkaline phosphatase, increased fibrillar 
collagen type I expression [10] and certain matrix proteins, e.g.
osteopontin (OPN), osteocalcin (OC), collagen type II and type X
[11–13]. Recent studies in human beings and animal models have
demonstrated that (as in mineralizing bone) arterial calcification is
inhibited by physiological function of resident cells (including
SMCs and endothelial cells) [14, 15]. Specifically, it was shown
that SMCs normally express inhibitors of mineralization, such as
inorganic pyrophosphate (PPi) and matrix gla protein (Mgp),
respectively, and that lack of these molecules leads to sponta-
neous vascular calcification and increased mortality [16, 17].
One of these inhibitors is the nucleotide pyrophosphatase/
phosphodiesterase (NPP) family member NPP1, because severe
inborn deficiency of NPP1 is associated with calcification of arteries
in mice and human beings [18, 19].
NPP1 is a major generator of extracellular PPi in cartilage and
a variety of other tissues, including heart, kidney, liver, pancreas
and skeletal muscle [20]. PPi potently inhibits hydroxyapatite
crystal deposition and growth and regulates chondrogenesis, col-
lagen I expression and synthesis [21] and other cell differentiation
processes [22]. These include promotion of the expression of
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OPN by PPi [19, 23], which in turn promotes atherogenesis via
recruitment of monocyte macrophages, and also inhibits arterial
calcification by effects that include suppression of hydroxyapatite
crystal growth [24].
The physiological role of NPP1-mediated PPi generation in 
tissue calcification has come to light recently. In human beings, inac-
tivating homozygous or inactivating compound heterozygous muta-
tions of ENPP1 are associated with generalized arterial calcification
of infancy (GACI), a frequently lethal form of disseminated arterial
media calcification and myointimal proliferation [25]. In Enpp1
knockout mice, hydroxyapatite crystals are found in the aortic medial
layer at the level of the internal elastic lamina [18]. These mice addi-
tionally develop abnormal calcification of periarticular tissues [23]. A
similar phenotype was found in the ttw/ttw mouse, harbouring a
homozygous truncation mutation in the Enpp1 gene [26, 27].
The role of NPP1 in atherogenesis and intimal calcification is
unknown. Previous studies have shown that the lack of Npp1 leads
to decreased expression of Opn in osteoclasts [23]. Opn is a known
chemoattractant for macrophages, the most prominent cell type in
atherosclerotic lesions [28]. Additionally, we have shown that
NPP1 expression is down-regulated in calcified plaques compared
to uncalcified atherosclerotic lesions in human carotid endarterec-
tomy samples [29]. We suggested that atherosclerotic lesion 
progression is attenuated and calcification in the atherosclerotic
plaque is enhanced due to a total or partial deficiency of Npp1. To
test our hypotheses, we crossed Npp1-deficient ttw/ttw mice with
ApoE-deficient mice to generate Npp1 and ApoE double deficient
mice. ApoE is a structural component of all lipoprotein particles
except low-density lipoprotein (LDL). It serves as a high-affinity 
ligand for lipoprotein receptors and thus allows the uptake of ApoE-
containing particles by the liver [30]. Mice deficient in ApoE show
increased serum cholesterol and triglycerides leading to athero-
sclerotic plaque development [31].
Our studies revealed that on the ApoE knockout background,
both partial and severe Npp1 deficiency (heterozygous and
homozygous ttw phenotype) slow down atherosclerotic lesion
progression. Furthermore, we found that partial Npp1 deficiency
was associated with a tendency towards greater intimal plaque
calcification. Thus, our results suggest that in the atherosclerotic
plaque NPP1 suppresses calcification but promotes atherogenesis.
Materials and methods
Mice
The creation of the Npp1-deficient ttw/ttw mouse [a breeding colony of a
ttw mice stock with ICR (Institute of Cancer Research) background in the
Central Institute for Experimental Animals (Kanagawa, Japan)] used in this
study has been described previously [27]. In this study, heterozygous mice
are designated as ttw/, Enpp1 wild-type as wt. C57BL/6 ApoE/ mice
(Jackson Laboratory, Bar Harbour, ME, USA) were bred to ttw/ mice.
Homozygous double-knockout ttw/ttw ApoE/ mice were generated 
by brother–sister mating of ttw/ ApoE/ mice on a ICR/C57BL/6 
background (1:1).
Enpp1 wt, Enpp1 heterozygous and Enpp1 null mice among ApoE null
mice were designated as wt ApoE/, ttw/ ApoE/ and ttw/ttw
ApoE/, respectively. Enpp1 and ApoE genotyping was performed by the
polymerase chain reaction analysis of tail DNA as described elsewhere
([27]; JAX® Mice database).
The study was approved by the local committee for animal studies
(Reg. No.: G21/2004).
Diet and experimental design
The pups were weaned at three weeks of age and then maintained on normal
chow diet. At eight weeks of age male littermates (18 ttw/ttw ApoE/, 18
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Fig. 1 RT-PCR analysis for chondro-osseous gene expression in cultured
aortic SMC preparations from wt ApoE/, ttw/ ApoE/ and ttw/ttw
ApoE/ mice. (A) Representative RT-PCR of one of four individual ani-
mals of each genotype is shown. (B) Relative expression of Opn corrected
for housekeeping gene Gapdh. Aortic SMC from 6-week-old mice were 
harvested as described in ‘Material and methods’. The mRNAs were studied
by RT-PCR in aliquots of 3  104 cells cultured for eight days as described
in ‘Material and methods’. Values represent the data mean  S.E.M. One-
way ANOVA was used to determine significant differences with Tukey’s post-
hoc analysis. *P  0.05, **P  0.001.
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ttw/ ApoE/ and 21 wt ApoE/) were set on high-fat/high-cholesterol
diet with 16% coconut oil, 1% cholesterol and 0.5% sodium cholate for 5,
10, 15 or 20 weeks. Mice were killed at 13, 18, 23 or 28 weeks of age.
Blood samples (0.5–0.8 ml) were obtained by retro-orbital bleed to assess
lipid profiles. The arterial tree was fixed by perfusion through the left ven-
tricle at physiological pressure using warmed (37C) 0.9% NaCl for 4 min.
followed by 4% (wt/vol) paraformaldehyde (pH 7.5) for 6 min. The aortic
arch, including its main branchpoints (brachiocephalic trunk, left common
carotid artery and left subclavian artery) were removed and fixed in 4%
paraformaldehyde. All vessels were processed and embedded longitudi-
nally in paraffin. The entire aortic arch was then cut into approximately 30
sections, and a series of 15 sections of 4 m thickness, which represented
the central area of the aortic arch with an intact morphology of the com-
plete arch, was used for analysis.
Plasma cholesterol and triglycerides
Whole blood obtained was centrifugated (5000 rpm, 5 min.) for separating
serum and stored at –20C. Total serum cholesterol and serum triglyceride
levels were determined in duplicate using commercially available enzy-
matic colorimetric assays (cholesterol CHOD-PAP and triglycerides GPO-
PAP; ProDiagnostica, Freiburg, Germany).
Histology and morphometry
For histological analysis, four sections (16 m apart), stained with
Elastica von Giesson were used for the morphometrical analysis. Elastica
von Giesson staining, which stains the elastic laminae, was used to delin-
eate the internal elastic lamina, to permit an easier distinction between
media and intima. The aortic arch region was defined as the aortic root
to approximately 1.5 mm caudal from the left subclavian artery branch-
point. Main branchpoints were also included into the measurements: the
brachiocephalic trunk, left common carotid artery and left subclavian
artery. Plaque area, excluding the underlying media, was determined for
each individual plaque as the number of pixels using Adobe Photoshop
CS3 extended (San Jose, CA, USA) [32]. Plaque area was converted to
square micrometres. Calcified areas were detected in von Kossa stainings
in the same serial sections and in the same manner used to determine
total plaque area; the relative calcification content was determined by
dividing calcified area by plaque area. Opn- and macrophages (M	)-
containing areas were detected by immunohistochemistry and deter-
mined in the same manner in which relative calcification content was
estimated. Haematoxylin and eosin standard stain demonstrated 
general morphology.
Immunohistochemistry
A goat antimouse antibody reacting against OPN, was used in this study
(R&D Systems GmbH, Wiesbaden-Nordenstadt, Germany). A monoclonal
antibody, reacting against monocytes and macrophages (clone MOMA-2)
was purchased from Serotec, Tokyo, Japan. The sections were stained with
OPN and MOMA-2 (1:50) followed by biotin-conjugated goat anti-rat IgG
followed by Streptavidin-biotin peroxidase complex (ABC Vectastain Elite
Kit; Vector Laboratories, Burlingame, CA, USA) and counterstained with
nuclear fast red or haematoxylin and eosin.
Isolation and culture of mouse SMCs
To isolate primary SMCs, the aorta of 6-week-old wt ApoE/, ttw/
ApoE/ and ttw/ttw ApoE/ mice was explanted, and cultured in
Dulbecco’s minimal Eagle medium (DMEM) containing 2% L-glutamine,
100 U/ml penicillin, 50 g/ml streptomycin and 20% foetal calf serum
(FCS) Gold (Lonza, Verviers, Belgium). The sprouted SMC were pas-
saged and cultured in DMEM containing 10% FCS Gold. Only cultures
containing more than 90% SMC specific 
-actin (using a monoclonal
antibody HHF35, 1:500; Dako Corporation, Carpenteria, CA, USA) and
SM22
 (using a monoclonal antibody 1B8, 1:250; Abcam plc,
Cambridge, UK) positive stained cells in passage 3 were used for total
RNA isolation.
RT-PCR analyses
Total RNA of SMC was isolated using RNeasy® Mini Kit (Qiagen GmbH,
Hilden, Germany). One microgram of total RNA was reverse-transcribed
after an initial denaturation step at 65C for 10 min. in a total volume of 
20 l using 10 U/l of Superscript™ III reverse transcriptase
(Invitrogen™ Life Technologies, Paisley, UK), 1 U/l Ribo Lock™ ribonu-
clease inhibitor (MBI Fermentas GmbH, St. Leon-Rot, Germany), 
25 ng/l oligo[(dT)12–18] (Invitrogen™ Life Technologies), 0.5 mmol/l
each of 2-desoxynucleoside-5triphosphate (dNTP), 5 mmol/l dithio-
threitol, 1 first strand buffer [250 mmol/l Tris-HCl (pH 8.4), 375 mmol/l
KCl, 15 mmol/l MgCl2] freshly diluted from 5 stock (Invitrogen™ Life
Technologies) at 37C for 60 min. Samples were heated at 95C for 
5 min. to terminate reverse transcriptase activity. Total reverse transcrip-
tion (RT) products were subsequently used for PCR amplification.
mRNAs of SMC specific Sm22
, Mgp, Opn, Oc and the housekeeping
gene Gapdh were assessed in aortic SMC.
The RT products (100 ng) were brought to a volume of 25 l contain-
ing 1 Qiagen GmbH PCR buffer, 2.5 mM MgCl2, 0.1 mM of each dNTP,
1.5 U of Taq Polymerase (Qiagen GmbH) and 0.4 M of each primer.
Primers were designed across intron/exon boundaries.
Table S1 summarizes the individual sequences of the primers,
annealing temperatures and cycle numbers used for each primer pair
and the PCR product sizes. After denaturation at 95C for 5 min. ampli-
fication was carried out in an Eppendorf Mastercycler® Gradient
(Eppendorf AG, Hamburg, Germany) using the following temperature
and time profile: denaturation at 95C for 30 sec.; primer annealing at
the respective temperatures for 60 sec.; primer extension at 72C for 
60 sec. and a final extension of 72C for 10 min. 10 l of the PCR reaction
were analysed using standard agarose gel electrophoresis. To evaluate
the relative expression, the agarose gels were scanned using a video
documentation system and analysed using ImageJ software (version
1.40g; ImageJ, imagej.nih.gov/ij/). The absorption units were corrected
for Gapdh mRNA levels.
Statistical analysis
Statistical analysis for comparison of multiple groups used one-way ANOVA
followed by the Tukey’s post hoc test, performed with GraphPad Prism
software (version 4.0, GraphPad software; San Diego, CA, USA). Results
were expressed as mean  S.E.M. Probability values 0.05 were consid-
ered statistically significant.
© 2011 The Authors
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Results
Npp1 deficiency decreases body weight without
affecting serum lipid levels in ApoE null mice
Feeding a high-fat/high-cholesterol diet to wt ApoE/, ttw/
ApoE/ and ttw/ttw ApoE/ mice caused hyperlipidemia
reflected by elevated serum cholesterol and triglycerides com-
pared to mice with normal chow diet (Table 1). There was no sig-
nificant difference between genotypes. Body weight measurement
revealed no difference between wt ApoE/ and ttw/ ApoE/
mice, but weights of these genotypes were significantly higher
than in ttw/ttw ApoE/ mice. High-fat/high-cholesterol diet had
no effect on body weight of all three genotypes compared to mice
fed with normal chow diet (Table 1).
Opn expression is decreased in Npp1-deficient
ApoE null aortic SMC
RNA preparations of cultured aortic SMC of wt ApoE/, ttw/
ApoE/ and ttw/ttw ApoE/ littermate mice, demonstrated
equal levels of expression of the SMC-specific marker sm22
 as
well as mgp (Fig. 1). The expression of Opn differed between the
genotypes. In cultured ttw/ ApoE/ SMC Opn expression was
down-regulated by approximately 14% compared to wt ApoE/
SMC (P  0.05), whereas Opn expression in ttw/ttw ApoE/
SMC was decreased by approximately 30% compared to wt
ApoE/ SMC (P  0.001).
Opn expression is decreased in Npp1-deficient
ApoE null atherosclerotic lesions
Opn was mainly present in areas of the plaque containing
macrophages (Fig. 2). These areas were also the major sites of
Enpp1 expression in the plaque (data not shown). After 28 weeks,
the relative Opn content in atherosclerotic lesions was significant
decreased in ttw/ttw ApoE/ mice compared to wt ApoE/ mice
(23.7%  11.6% versus 47.0%  9.9%, P 0.05, Figs 2A, E and
S1). The relative Opn-containing area was lower by trend in ttw/
ApoE/ mice compared with wt ApoE/ mice (34.7%  11.1%
for ttw/ ApoE/ versus 47.0%  9.9% for wt ApoE/ mice,
P  0.1; Figs 2A, C, E and S1).
The macrophages-containing area expressed as percentage of
total lesion area was smaller by trend in ttw/ttw ApoE/ mice com-
pared with ttw/ ApoE/ and wt ApoE/ mice (22.2%  14.2%
for ttw/ ApoE/ versus 35.7%  10.3% for ttw/ ApoE/ and
43.7%  14.9% for wt ApoE/mice, P 0.1; Figs 2B, D, F and S1).
© 2011 The Authors
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Table 1 Serum cholesterol levels, serum triglyceride levels and body weight measurement in wt ApoE/, ttw/ ApoE/ and ttw/ttw ApoE/
mice at different ages
wt ApoE/ ttw/ ApoE/ ttw/ttw ApoE/
Time (weeks) High-fat diet Control diet High-fat diet Control diet High-fat diet Control diet
Cholesterol (mg/dl) 13 635  39 141  91* 541  181* 138  24* 705  135 122  51*
18 547  260 88  48* 631  83* 116  55* 685  35 122  60*
23 467  222 54  27* 501  70* 80  47* 492  156 107  27*
28 589  256 62  37* 515  306* 97  72* 648  332 65  55*
Triglycerides (mg/dl) 13 634  71 150  73* 622  63* 168  86* 513  178 142  88*
18 328  108 129  39* 310  180* 124  38* 396  168 124  23*
23 493  87 125  94* 333  106* 150  65* 414  262 151  47*
28 361  105 128  70* 350  86* 130  59* 297  166 112  33*
Body weight (g) 13 22.5  3.4 24.5  1.7 22.0  2.2 24.6  4.9 19.3  3.6 20.2  2.3
18 26.1  2.9 27.2  2.6 29.0  4.9 29.3  4.0 20.4  2.5# 21.2  5.2
23 34.2  4.4 29.1  3.6 33.8  5.0 29.1  2.9 20.7  3.4## 23.0  2.9#
28 33.6  2.9 32.0  0.6 31.3  2.8 30.3  3.5 21.7  2.8## 22.4  2.6##
For serum cholesterol and triglycerides samples, blood was obtained by retro-orbital venipuncture from mice with high-fat/high-cholesterol diet
(high-fat diet) and from mice fed with normal chow diet (control diet). Data are presented as mean  S.D. for n  4–6 mice. One-way ANOVA was
used to determine significant differences with Tukey’s post-hoc analysis comparing results from different genotypes.
*P  0.05 versus mice with high-fat/high-cholesterol diet, #P  0.01 and ##P  0.005, both versus wt ApoE/ and ttw/ ApoE/ mice.
J. Cell. Mol. Med. Vol 15, No 11, 2011
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Absence of Npp1 attenuates atherosclerosis 
in ApoE null mice
Mice of the three genotypes were analysed at 13, 18, 23 or 28
weeks of age. At the age of 13 weeks, 60% of ttw/ttw ApoE/,
80% of ttw/ ApoE/ and 100% of wt ApoE/ mice developed
atherosclerotic plaques in the aortic arch (Table 2). One hundred
percent of older mice of all genotypes showed plaque develop-
ment. The atherosclerotic lesion area in the aortic arch was care-
fully determined on 57 mice. Individual data points plotted by
genotype and age are presented in Figure 4. There were no signif-
icant differences in the mean lesion area in the aortic arch between
groups at 13, 18 and 23 weeks of age (Figs 3A–C, 4A–C and 
Table 2). However, in 28-week-old mice, ttw/ ApoE/ and
ttw/ttw ApoE/ mice had significantly smaller atherosclerotic
lesions compared with wt ApoE/ mice (*P  0.05 for ttw/ttw
ApoE/ versus wt ApoE/, **P  0.01 for ttw/ ApoE/
versus wt ApoE/; Figs 3D–F, 4D and Table 2). This finding was
Fig. 2 Representative stainings of Opn and
macrophages in atherosclerotic lesions of
28-week-old mice. Opn (brown, A, C, E) and
macrophages (brown, B, D, F) immunohis-
tochemistry in wt ApoE/ (A, B), ttw/
ApoE/ (C, D) and ttw/ttw ApoE/ (E, F)
mice fed a high-fat/high-cholesterol diet.
Table 2 Summary of frequency of atherosclerotic lesions and mean atherosclerotic lesion areas
Values represent the mean  S.E.M. Numbers in parenthesis indicate number of affected mice to number of mice in each group. One-way ANOVA
was used to determine significant differences with Tukey’s post-hoc analysis.
*P  0.05 versus wt ApoE/ mice, **P  0.01 versus wt ApoE/ mice.
Genotype 13 weeks 18 weeks 23 weeks 28 weeks
Frequency of lesions
wt ApoE/ 100% (4/4) 100% (6/6) 100% (6/6) 100% (5/5)
ttw / ApoE/ 80% (4/5) 100% (4/4) 100% (5/5) 100% (4/4)
ttw /ttw ApoE/ 60% (3/5) 100% (5/5) 100% (4/4) 100% (4/4)
Mean area of atherosclerotic lesion in m2
wt ApoE/ 3.9  1.8 108.4  34.7 272.8  48.0 997.7  173.2
ttw / ApoE/ 3.2  1.3 61.5  35.8 167.8  28.0 353.7  26.3 **
ttw /ttw ApoE/ 5.8  2.9 109.0  38.1 222.4  31.6 404.7  54.8 *
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consistent when normalizing the lesion areas to the respective
body weights of the animals (Fig. S2).
Npp1 deficiency increases both media 
and atherosclerotic plaque calcification 
in ApoE null mice
von Kossa staining demonstrated aortic media calcifications in
60% of 13-week-old, 80% of 18-week-old and 100% of older
ttw/ttw ApoE/ mice, whereas ttw/ ApoE/ and wt ApoE/
mice were totally devoid of medial calcification (Fig. 3G–I and
Table 3). At the age of 28 weeks, plaque calcification developed in
all genotypes, in 60% of wt ApoE/ and 75% of ttw/ ApoE/
and ttw/ttw ApoE/ mice (Fig. 3D–F). There was a non-signifi-
cant increase in mean size of calcified areas in the intimal layer of
ttw/ttw ApoE/ and ttw/ ApoE/ compared with wt ApoE/
mice (1332 m2  763.2 for ttw/ttw ApoE/ and 1286 m2 
621.1 for ttw/ ApoE/ versus 598 m2 290.7 for wt ApoE/
mice, P  0.36 and P  0.32; Fig. 5C and Table 3). When
expressed as percentage of total lesion area, the calcified lesion
area was greater by trend in ttw/ ApoE/ mice compared with
wt ApoE/ mice (39.7%  19.2% for ttw/ ApoE/ versus
6.4%  2.8% for wt ApoE/ mice, P  0.1; Fig. 5D and Table 3).
Discussion
Our study was consistent with prior findings of media calcifica-
tions in the aorta of severely Npp1-deficient mice in the absence
© 2011 The Authors
Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 3 Representative aortic root sections of 28-week-old mice. wt ApoE/ (A, D, G), ttw/ ApoE/ (B, E, H) and ttw/ttw ApoE/ (C, F, I) mice fed a
high-fat/high-cholesterol diet. Haematoxylin and eosin stained sections (A–C) of the whole aortic arch. Von Kossa staining for calcifications (brown,
arrows) of atherosclerostic lesions (D–F) and the aortic wall (G–I).
J. Cell. Mol. Med. Vol 15, No 11, 2011
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Table 3 Summary of frequency of medial and intimal calcifications, mean calcified areas and calcified area expressed as percentage of total lesion area
Values represent the mean  S.E.M. Numbers in parenthesis indicate number of mice in each group. One-way ANOVA was used to determine signif-
icant differences with Tukey’s post-hoc analysis.
aP  0.1 versus wt ApoE/ mice.
Genotype Region 13 weeks 18 weeks 23 weeks 28 weeks
Frequency of calcifications
wt ApoE/ Media 0% (0/4) 0% (0/6) 0% (0/6) 0% (0/5)
Intima 0% (0/4) 17% (1/6) 33% (2/6) 60% (3/5)
ttw / ApoE/ Media 0% (0/5) 0% (0/4) 0% (0/5) 0% (0/4)
Intima 0% (0/5) 0% (0/4) 0% (0/5) 75% (3/4)
ttw /ttw ApoE/ Media 60% (3/5) 80% (4/5) 100% (4/4) 100% (4/4)
Intima 0% (0/5) 0% (0/5) 25% (1/4) 75% (3/4)
Mean area of intimal calcifications in m2
wt ApoE/ 0 113  113 516.5  347.3 598  290.7
ttw/ ApoE/ 0 0 0 1286  621.1
ttw /ttw ApoE/ 0 0 50.25  50.25 1332  763.2
Calcified area as percentage of total lesion area
wt ApoE/ 0% 12.6%  12.6% 16.1%  10.5% 6.4%  2.8%
ttw/ ApoE/ 0% 0% 0% 39.7%  19.2%a
ttw /ttw ApoE/ 0% 0% 1.8%  1.8% 30.4%  15.9%
Fig. 4 Mean atherosclerosis lesion area in
individual mice sorted by genotype and age.
Mean lesion area in m2 was calculated in
13 (A), 18 (B), 23 (C) and 28-week-old mice
(D). Bars represent the data mean. One-way
ANOVA was used to determine significant 
differences with Tukey’s post-hoc analysis.
*P  0.05 versus wt ApoE/ mice, **P 
0.01 versus wt ApoE/ mice.
2280 © 2011 The Authors
Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
of atherosclerosis [18, 26] (and own unpublished results).
Interestingly, we did not observe any medial calcification in
ttw/ mice with atherosclerosis, suggesting that one functional
copy of Enpp1 transcript is sufficient to suppress media calcifi-
cation. Instead, advanced plaques of 28-week-old ttw/
ApoE/ mice showed a tendency of an increase in the calcified
to total lesion area ratio compared to wt ApoE/ mice, suggest-
ing that function- or expression-impairing mutations on one
allele of ENPP1 may lead to increased calcified areas in late
stages of atherogenesis. However this result was not statistically
significant, which may be due to limited power of our study. Our
results suggest that expression of NPP1 in the arterial wall is
necessary to suppress intimal plaque calcification. This finding
is in line with our previous study showing that NPP1 expression
is down-regulated in calcified plaques compared to uncalcified
atherosclerotic lesions in human carotid endarterectomy sam-
ples [29]. Interestingly, several studies on the K173Q genotype
of ENPP1 in adults associated this with coronary calcification,
aortic stiffness, myocardial infarction and earlier onset of periph-
eral arterial disease [33, 34]. Accordingly, we previously demon-
strated a small decrease in enzymatic activity of the K173Q vari-
ant of NPP1 in vitro [16]; however, levels of enzymatic NPP1
activity in patients carrying this variant on one allele have not
been studied yet.
In our study we show that, although one copy of ENPP1 is 
sufficient to suppress media calcification, it is not sufficient to
suppress intima calcification in the context of atherosclerosis in
mice. We would therefore speculate that those patients carrying
the K173Q polymorphism of ENPP1 have an increased risk of
intima calcification instead of media calcification. Conversely
these patients might have a decreased atherosclerotic lesion bur-
den compared to the general population.
In the current study, we show that in ApoE-deficient mice with
total absence as well as with the partial loss of Npp1 Opn expres-
sion is reduced, leading to reduced Opn-containing areas in ather-
osclerotic lesions. Previous studies showed decreased Opn levels
in Enpp1/ mice osteoblast and arterial SMC [18, 23, 35].
Studies on different proteins involved in PPi metabolism, e.g.
NPP1, the multiple-pass transmembrane protein ANK and the tis-
sue non-specific alkaline phosphatase, determined that OPN
expression is directly regulated by extracellular PPi levels [23, 36].
That reduced OPN levels correlate with reduced plaque size has
been shown previously. Matsui et al. described 30–40% smaller
atherosclerotic lesion areas in 36-week-old female Opn-deficient
atherosclerotic (Opn/ApoE null) mice compared with ApoE null
mice, due to less macrophages and lymphocytes in the lesion
[37]. Also, in female 34-week-old Opn/ ApoE/ LDL receptor triple
knockout mice, atherosclerotic lesion area is reduced compared
with ApoE/ LDL receptor deficient mice [38]. Furthermore, it has
been shown that transgenic mice that overexpress Opn are more
prone to develop fatty streaks than wild-type mice [39]. We also
found that the infiltration of macrophages in atherosclerotic
lesions in Npp1-/ApoE-deficient mice was less extensive com-
pared with ApoE-deficient mice by trend. These results are consis-
tent with previous findings that OPN is a chemoattractant for
macrophages [28]. We speculate that decreased Opn expression
associated with Npp1 deficiency is a likely mediator of decreased
atherogenesis in our mouse model.
Fig. 5 Calcified areas in individual mice,
sorted by genotype and age. Mean calcified
area in m2 (A and C) and calcified area
expressed as percentage of total lesion area
(B and D) determined in 23- (A and B) and
28- (C and D) week-old mice. Bars represent
the data mean. One-way ANOVA was used to
determine significant differences with
Tukey’s post-hoc analysis. aP  0.1 versus
wt ApoE/ mice.
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Taken together, our study revealed that absolute NPP1 defi-
ciency caused by a homozygous null mutation as well as partial
deficiency caused by heterozygosity in the ENPP1 locus promote
intimal plaque calcification and attenuate atherosclerotic lesion
progression. Thus, although mutations on both ENPP1 alleles lead
to GACI, mutations on one allele might be protective against ath-
erosclerosis. Decreased OPN expression associated with NPP1
deficiency is a likely mediator of decreased atherogenesis but also
likely promotes atherosclerotic plaque calcification.
Limitations of the study
Our study was limited by the short lifespan of Npp1-deficient
mice, which is caused by the severity of the skeletal phenotype
resulting in a feeding disorder. We had to accelerate atheroscle-
rotic lesion development in Npp1 and ApoE double deficient mice
by feeding a cholesterol-rich diet, because Npp1-deficient mice
usually survive no longer than 30 weeks. For the atherosclerotic
ApoE-deficient mice on chow diet, Rattazzi et al. described small
areas of plaque calcification apparent between 45 and 60 weeks of
age at the earliest [40]. In our study, because the atherogenesis
was accelerated by a high-fat/high-cholesterol diet, we were not
able to investigate effects of Npp1 deficiency on ‘natural’ plaque
development in ApoE null mice.
Conclusions
Based on the results of our current study and previous work [29],
we propose a novel model for modulation of NPP1 expression and
the role of NPP1 in promotion of atherogenesis and suppression
of intimal plaque calcification (Fig. 6). NPP1 generates PPi and
thereby promotes OPN expression [23, 36], which is a known
chemoattractant for monocyte macrophages [28]. It is known,
that NPP1 is up-regulated by transforming growth factor (TGF)-
[41] and down-regulated by interleukin (IL)-1 [42]. During 
atherosclerotic lesion progression, the expression of pro-
inflammatory cytokines including IL-1 is increased [43, 44],
whereas TGF- responsiveness is suppressed [45]. We speculate
that this shift within lesions associated with decreased TGF-
responsiveness and increased inflammation including IL-1
expression could account for the drop in NPP1 expression in 
atherosclerotic lesions. This effect, linked with decreased PPi
generation and inhibition of OPN expression has the capacity to
promote calcification. It will be of interest to test this paradigm
more directly in further in vivo studies.
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Fig. 6 Model for modulation of NPP1 expression and role of NPP1 in
atherogenesis and suppression of intimal plaque calcification based on
results of promotion of atherosclerotic lesion development but suppres-
sion of intimal plaque calcification. This model is based on the results of a
previous study that showed regulated expression of NPP1 and OPN in
human atherosclerotic lesions [29], and is based on the results of the cur-
rent study in ApoE knockout mice with partial and severe deficiency of
Npp1 in ttw/ and ttw/ttw mice. NPP1 generates PPi and thereby pro-
motes OPN expression that promotes progression of atherogenesis.
However, a shift within lesions to decreased TGF- responsiveness [45]
and increased inflammation including IL-1 expression [43, 44] could
account for the previously described drop NPP1 expression in atheroscle-
rotic lesion cells including SMCs. This effect, linked with decreased PPi
generation and inhibition of OPN expression, promotes plaque calcifica-
tion. We observe increased atherosclerotic plaque calcification in Npp1-
/ApoE-deficient lesions in vivo in this study.
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Fig. S1 Opn- and macrophages-containing areas in individual 28-
week-old mice, sorted by genotype. Area containing Opn (A) and
macrophages (B) expressed as percentage of total lesion area in
28-week-old mice. Bars represent the data mean. One-way ANOVA
was used to determine significant differences with Tukey’s post
hoc analysis. *P  0.5, aP  0.1.
Fig. S2 Mean lesion area normalized on body weight, sorted 
by genotype. Values represent mean lesion data in m2 pro g
body weight. One-way ANOVA was used to determine significant 
differences with Tukey’s post hoc analysis. *P  0.05 versus
wt ApoE/ mice, **P  0.01 versus wt ApoE/ mice.
Table S1 Primer and PCR characteristics
Please note: Wiley-Blackwell is not responsible for the content or
functionality of any supporting materials supplied by the authors.
Any queries (other than missing material) should be directed to
the corresponding author for the article.
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